RWD135 TRENDS IN THE INCORPORATION OF CLINICAL OUTCOME ASSESSMENTS IN ASTHMA DRUG DEVELOPMENT IN JAPAN: A FIVE-YEAR REVIEW (2020-2024)
Clinical outcome assessments (COAs) are essential for evaluating treatment benefits from a patient-centred perspective. Between 2010 and 2019, only 2% (n=10) of asthma products in Japan incorporated patient-reported outcomes. This study aims to follow up on that analysis by examining the progress of COA inclusion in asthma drug development between 2020 and 2024.
Authors
- Yoko Sakai
- Bruce Crawford (ORCID: https://orcid.org/0000-0001-9109-728X)
Publication Details
- Journal
- Value in Health Regional Issues
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1016/j.vhri.2025.101364
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00